Skip to main content

Josep Castellví Vives

Institutions of which they are part

Senior researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Josep Castellví Vives

Institutions of which they are part

Senior researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Projects

Anatomia Patològica (GRC)

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Cleofé Romagosa Pérez-Portabell, Inés de Torres Ramirez, Angel García Jiménez, Josep Castellví Vives, Maria Teresa Salcedo Allende, Javier Hernandez Losa, Marta Sese Faustino, Vicente Peg Camara, Irene Sansano Valero, Stefania Landolfi , Trond Aasen
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2014 SGR 1131
Duration: 01/01/2014 - 31/12/2016

Desarrollo de Marcadores y Terapias en Cáncer de Endometrio Avanzado

IP: Antonio Gil Moreno
Collaborators: Angel García Jiménez, Maria Asuncion Perez Benavente, Fco Javier De la Torre Fdez de Vega, Josep Castellví Vives, Silvia Cabrera Diaz
Funding agency: Instituto de Salud Carlos III
Funding: 147620
Reference: PI14/02043
Duration: 01/01/2015 - 30/06/2019

Nuevas estrategias terapéuticas para el cáncer de mama: uso de inhibidores de las MNKs y caracterización de nuevos factores que confieren resistencia al estrés celular.

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Maria Rosa Somoza Lopez de Haro, Jordi Temprana Salvador, Roso Marès Pagès, Teresa Moline Marimon, Josep Castellví Vives, Maria Teresa Salcedo Allende, Marta Sese Faustino
Funding agency: Instituto de Salud Carlos III
Funding: 272552.5
Reference: PI14/01320
Duration: 01/01/2015 - 31/03/2018

Identificación de perfiles de microRNAs (miRNAs) asociados a corta o larga supervivencia en pacientes con cáncer de ovario avanzado, para mejorar la eficacia del tratamiento

IP: Identificación de perfiles de microRNAs (miRNAs) asociados a corta o larga supervivencia en pacientes con cáncer de ovario avanz
Collaborators: Angel García Jiménez, Josep Castellví Vives, Antonio Gil Moreno
Funding agency: Fundació Santiago Dexeus Font
Funding: 6000
Reference: DEXEUS-B29/012
Duration: 25/01/2013 - 25/01/2015

Related news

The ten groups within the Cancer Area combine basic, translational and clinical research to identify new targets, biomarkers and therapeutic strategies

The grants promote new therapeutic strategies and diagnostic tools in highly complex tumors such as glioblastoma, triple-negative breast cancer, and endometrial cancer.

The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.

Related professionals

Candida Driemeyer

Candida Driemeyer

Junior researcher
Clinical Neuroimmunology
Read more
Rosario Pardo  Diaz

Rosario Pardo Diaz

Research technician
Diabetes and Metabolism
Read more
Maria Pieras Lopez

Maria Pieras Lopez

Senior researcher
Infection and immunity in pediatric patients
Read more
Eduard Albuixech Ginesta

Eduard Albuixech Ginesta

Research assistant
Molecular Imaging and Therapy
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.